Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  General Oncology
  •  Hormone Therapy
  •  Paediatric Cancers
  •  Chemoprevention
  •  Kidney Cancer
  •  Palliative Care
  •  Endoscopy Methods
  •  Chemotherapy and Radiotherapy

Welcome

Clinics in Oncology™ (Impact Factor: 2.709*) and (ISSN 2474-1663) is an interdisciplinary and borderless journal serves as the most reputable and authoritative platform for distributing key clinical oncology research to its readers, associated with Breast Cancer, Gastrointestinal Cancer, Hematologic Malignancies, Molecular Oncology, Thoracic Cancer, Genitourinary Cancer, Head and neck Cancer, Cervical Cancer, Bladder Cancer, Colon Cancer, Colorectal Cancer, Lung Cancer, Pediatric Cancer, Ovarian Cancer, Prostate Cancer, Surgical Oncology, Pediatric Oncology, Neuro-Oncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readers include active clinical oncologists in practice, researchers, students, trainees, and allied health professionals worldwide.

Clinics in Oncology™ (Impact Factor: 2.709*) encircles a wide range of informative and advanced articles that contribute significantly to the field of oncology. The journal's scope covers various aspects of oncology research, including basic science, translational research, clinical studies, and reviews.

NLM ID

[PubMed NLM ID]

Recently Published Articles

Evaluation of Screening Program for Hepatocellular Carcinoma at a Single Center

El-Azab Ahmed GI, Ahmed El-Helw GA, Ahmed El-Sabawy MM, Samy Kohla MA and Muhammed Omar YA

 Abstract  PDF  Full Text Research Article | Open Access

Citation: Clin Oncol. 2024;9(1):2100. DOI: 10.25107/2474-1663.2100

Five-Year Complete Remission in Super-Giant Hepatocellular Carcinoma with Hepatectomy Followed by Sorafenib Plus Camrelizumab: A Case Report

Zheng X, Sun L, Jin W, Liu H, Song W, Xu H, Wu J, Wang X, Gou C and Ding H

 Abstract  PDF  Full Text Case Report | Open Access

Citation: Clin Oncol. 2024;9(1):2099. DOI: 10.25107/2474-1663.2099

Personalized Approach in the Treatment of Triple Negative Breast Cancer: Literature Review and Perspectives

Popov AY, Karmazanovsky GG, Ryabov KY, Andreenko EA, Simonov AD, Gritskevich AA, Makarov VA, Dmitrieva TA and Oluwatchegun OM

 Abstract  PDF  Full Text Review Article | Open Access

Citation: Clin Oncol. 2024;9(1):2097. DOI: 10.25107/2474-1663.2097

PD-L1: A Window for Oral Cancer Therapeutics

Poonam G, Vaibhav G, Neena C, Deepak G, Usha A and Garima J

 Abstract  PDF  Full Text Research Article | Open Access

Citation: Clin Oncol. 2024;9(1):2095. DOI: 10.25107/2474-1663.2095

Search Our Journal

Journal Indexed In

Articles in PubMed

NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Influence of Hydrocortisone in Chemotherapy and Photodynamic Therapy in HEp-2 Cells
 Abstract  PDF  Full Text
NLRP3 Inflammasome Enhances Tumor Growth
 Abstract  PDF  Full Text
View More...